Skip to content
value.today
Mereo Biopharma Group logo

Mereo Biopharma Group

MAH0.SG
$400 Mlast known market cap, Jan 2024 — no current value
Compare
World rank
—
no current market cap
Revenue
$1 M
For year ending December-2025
value.today research
Net income
$42 M
8376.0% margin
value.today research
Employees
39
As of December 31, 2025
value.today research

Mereo Biopharma Group in brief

Mereo Biopharma Group is a listed company in the Biotechnology industry, based in the UK. Its last known market value was $400 M (January 2024); there is no current figure. In the year to December 2025 it had sales of $0 M and a net profit of $42 M. It employs about 39 people. Its shares trade under the symbol MAH0.SG (Nasdaq).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About Mereo Biopharma Group

We are a biopharmaceutical company focused on the development of innovative therapeutics for rare diseases. We have developed a portfolio of late-stage clinical product candidates. Our late-stage rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta and alvelestat for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease. Setrusumab has received orphan designation for OI from the European Commission and the FDA, PRIME designation from the EMA and has Breakthrough Therapy designation and rare pediatric disease designation from the FDA. Alvelestat has received orphan designation for AATD from the EC and the FDA, and Fast Track designation for the treatment of AATD-LD from the FDA. We also have an early-stage rare disease program, vantictumab, for the treatment of a second bone disease, autosomal dominant osteopetrosis Type 2. The global development of vantictumab is being funded and led by our partner, āshibio, and we retain the European commercial rights.

Market cap history

$0 M$108 M$216 M$324 M$432 M20202021202220232024

World rank over time

▲ up 7,665 places since 2020
2020-01-01: #21637#21,63720202021-01-01: #17858#17,85820212022-01-07: #20131#20,13120222022-12-25: #23476#23,47620222023-07-30: #19765#19,76520232024-01-05: #13972#13,9722024

Rank in UK: #476 (Jan 2020) · #623 (Jan 2021) · #884 (Jan 2022) · #911 (Dec 2022) · #778 (Jul 2023) · #485 (Jan 2024)

Key ratios

market cap and latest results
P/E ratio
—
Price / sales
—
Price / book
—
Free cash flow yield
—
Net margin
8376.0%
Operating margin
-8022.0%
Return on equity
102.3%
Liabilities / assets
10.9%
Revenue per employee
$13 K
Profit per employee
$1.1 M

Annual results

Revenue
$1 M
Operating income
$-40 M
Net income
$42 M

For year ending December-2025

Balance sheet

Total assets
$46 M
Total liabilities
$5 M
Total equity
$41 M

As of December-2025

How Mereo Biopharma Group compares in Biotechnology

Peer comparison · Biotechnology

CompanyMarket capP/ENet marginRev. growth
Mereo Biopharma Group🇬🇧$400 M———
Novo Nordisk A/S🇩🇰$203.2 B13.1×33.1%+10.8%
Vertex Pharmaceuticals Incorporated🇺🇸$134.3 B33.8×30.7%+8.9%
Moderna, Inc.🇺🇸$90.1 B—-110.5%-39.9%
Regeneron Pharmaceuticals, Inc.🇺🇸$84.1 B17.5×28.5%+1.0%
Argenx SE🇳🇱$52.8 B40.9×31.1%+89.9%
CSL Limited🇦🇺$51.6 B—-16.4%—
Samsung Biologics Co., Ltd.🇰🇷$51.5 B40.5×39.2%—
UCB SA🇧🇪$48.6 B26.3×20.1%+31.1%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Jan 5, 2024 (last known)
Annual results:
For year ending December-2025
Balance sheet:
As of December-2025
Employees:
As of December 31, 2025
Profile updated:
Nov 15, 2026

Figures from value.today research.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Mereo Biopharma Group? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Mereo Biopharma Group's ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Mereo Biopharma Group? Suggest a correction